Literature DB >> 6726006

Dose response of influenza A/Washington/897/80 (H3N2) cold-adapted reassortant virus in adult volunteers.

M L Clements, R F Betts, H F Maassab, B R Murphy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6726006     DOI： 10.1093/infdis/149.5.814

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  12 in total

1.  Four viral genes independently contribute to attenuation of live influenza A/Ann Arbor/6/60 (H2N2) cold-adapted reassortant virus vaccines.

Authors:  M H Snyder; R F Betts; D DeBorde; E L Tierney; M L Clements; D Herrington; S D Sears; R Dolin; H F Maassab; B R Murphy
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

2.  Resistance of adults to challenge with influenza A wild-type virus after receiving live or inactivated virus vaccine.

Authors:  M L Clements; R F Betts; E L Tierney; B R Murphy
Journal:  J Clin Microbiol       Date:  1986-01       Impact factor: 5.948

3.  Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine.

Authors:  M L Clements; B R Murphy
Journal:  J Clin Microbiol       Date:  1986-01       Impact factor: 5.948

4.  Response of seronegative and seropositive adult volunteers to live attenuated cold-adapted reassortant influenza A virus vaccine.

Authors:  M L Clements; E L Tierney; B R Murphy
Journal:  J Clin Microbiol       Date:  1985-06       Impact factor: 5.948

5.  Attenuation of wild-type human influenza A virus by acquisition of the PA polymerase and matrix protein genes of influenza A/Ann Arbor/6/60 cold-adapted donor virus.

Authors:  M H Snyder; M L Clements; D De Borde; H F Maassab; B R Murphy
Journal:  J Clin Microbiol       Date:  1985-11       Impact factor: 5.948

6.  Safety of and serum antibody response to cold-recombinant influenza A and inactivated trivalent influenza virus vaccines in older adults with chronic diseases.

Authors:  G J Gorse; R B Belshe; N J Munn
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

7.  Evaluation of cold-recombinant influenza A/Korea (CR-59) virus vaccine in infants.

Authors:  E L Anderson; R B Belshe; B Burk; J Bartram; H F Maassab
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

8.  Evaluation of live avian-human reassortant influenza A H3N2 and H1N1 virus vaccines in seronegative adult volunteers.

Authors:  M H Snyder; M L Clements; R F Betts; R Dolin; A J Buckler-White; E L Tierney; B R Murphy
Journal:  J Clin Microbiol       Date:  1986-05       Impact factor: 5.948

9.  Evaluation of avian-human reassortant influenza A/Washington/897/80 x A/Pintail/119/79 virus in monkeys and adult volunteers.

Authors:  M L Clements; M H Snyder; A J Buckler-White; E L Tierney; W T London; B R Murphy
Journal:  J Clin Microbiol       Date:  1986-07       Impact factor: 5.948

10.  Local and systemic antibody responses in high-risk adults given live-attenuated and inactivated influenza A virus vaccines.

Authors:  G J Gorse; R B Belshe; N J Munn
Journal:  J Clin Microbiol       Date:  1988-05       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.